1. Home
  2. NRXP vs MOBX Comparison

NRXP vs MOBX Comparison

Compare NRXP & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • MOBX
  • Stock Information
  • Founded
  • NRXP 2015
  • MOBX 2020
  • Country
  • NRXP United States
  • MOBX United States
  • Employees
  • NRXP N/A
  • MOBX N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • MOBX
  • Sector
  • NRXP Health Care
  • MOBX
  • Exchange
  • NRXP Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • NRXP 32.6M
  • MOBX 34.2M
  • IPO Year
  • NRXP N/A
  • MOBX N/A
  • Fundamental
  • Price
  • NRXP $3.50
  • MOBX $0.74
  • Analyst Decision
  • NRXP Strong Buy
  • MOBX
  • Analyst Count
  • NRXP 4
  • MOBX 0
  • Target Price
  • NRXP $28.50
  • MOBX N/A
  • AVG Volume (30 Days)
  • NRXP 295.0K
  • MOBX 229.8K
  • Earning Date
  • NRXP 08-13-2025
  • MOBX 08-13-2025
  • Dividend Yield
  • NRXP N/A
  • MOBX N/A
  • EPS Growth
  • NRXP N/A
  • MOBX N/A
  • EPS
  • NRXP N/A
  • MOBX N/A
  • Revenue
  • NRXP N/A
  • MOBX $10,692,000.00
  • Revenue This Year
  • NRXP N/A
  • MOBX N/A
  • Revenue Next Year
  • NRXP N/A
  • MOBX N/A
  • P/E Ratio
  • NRXP N/A
  • MOBX N/A
  • Revenue Growth
  • NRXP N/A
  • MOBX 450.28
  • 52 Week Low
  • NRXP $1.10
  • MOBX $0.55
  • 52 Week High
  • NRXP $6.01
  • MOBX $2.47
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 66.15
  • MOBX 53.50
  • Support Level
  • NRXP $2.90
  • MOBX $0.64
  • Resistance Level
  • NRXP $3.61
  • MOBX $0.84
  • Average True Range (ATR)
  • NRXP 0.28
  • MOBX 0.08
  • MACD
  • NRXP -0.03
  • MOBX 0.00
  • Stochastic Oscillator
  • NRXP 64.59
  • MOBX 45.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

Share on Social Networks: